InvestorsHub Logo
Followers 0
Posts 123
Boards Moderated 0
Alias Born 03/23/2017

Re: None

Tuesday, 01/23/2018 4:33:20 PM

Tuesday, January 23, 2018 4:33:20 PM

Post# of 10345
Found this on Yahoo finance:erryyesterday
Purastat is the same product as AC5. Look at their website. 3D licensed the technology from MIT at the same time as Arch. They not only have the technology approved for external and internal use as a hemostat but for several other uses too. Arch doesn't even have external use filed yet. Am I the only one that sees a problem with this?

Anyone know anything about this. I thought Arch had exclusive rights?